Keyphrases
Antiretroviral Therapy
16%
Antiretroviral Therapy Interruption
16%
Atazanavir
8%
Baseline Factors
8%
Bazett
8%
Boosted Protease Inhibitors
100%
Clinical Significance
8%
Conservation Groups
16%
Corrected QT
8%
Heart Rate
8%
Interval Duration
8%
Linear Regression Analysis
8%
Lopinavir
16%
Minimal Impact
8%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
PR Interval
25%
Protease Inhibitors
100%
QT Interval
8%
Ritonavir-boosted Protease Inhibitors
8%
Saquinavir
8%
Viral Suppression
25%
Pharmacology, Toxicology and Pharmaceutical Science
Atazanavir
5%
Lopinavir
10%
Nonnucleoside Reverse Transcriptase Inhibitor
31%
Pharmacotherapy
5%
Proteinase Inhibitor
100%
Ritonavir
5%
Saquinavir
5%